Aussie Report Says Drug Firms Skirt Generics Price Caps With Combos
This article was originally published in PharmAsia News
Executive Summary
A medical study accused drug makers of combining medicines to skirt Australia rules designed to maintain low prices for generics on the nation's pharmaceutical subsidy program.